Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer

Open access

Published version of a preprint

Abstract

Purpose: SMAD4 loss is associated with the development of metastases and poor prognosis. We evaluated expression of SMAD4 protein and its association with tumor characteristics, including biomarkers and outcome in terms of relapse-free survival and overall survival. Experimental design: We used 1,564 stage II/III colon cancer samples from PETACC-3 to evaluate SMAD4 expression by immunohistochemistry. SMAD4 protein expression was validated by assessing mRNA expression using available expression array data. SMAD4 expression was also studied on 34 adenomas and 10 colon cancer liver metastases with their primaries. Loss of SMAD4 immunoreactivity was defined as focal or diffuse. Cases without SMAD4 loss were subdivided into those with strong and weak expression. Results: SMAD4 protein expression was informative in 1,381/1,564 cases. SMAD4 loss was found in 293/1,381 (21%) cases. Of 1,088 cases without SMAD4 loss (79%), 530 showed weak and 558 strong expression. SMAD4 loss occurred also in adenomas, but less extensively than in carcinomas. Liver metastases followed mostly the expression pattern of the primary tumor. SMAD4 loss, including weak expression, identified patients with poor survival in stage II as well as III and in both treatment arms. SMAD4 loss was less frequent in tumors with microsatellite instability and more frequent in those with loss of heterozygosity of 18q. Conclusions: We conclude that clonal loss of SMAD4 expression in adenomas, carcinomas, and liver metastases increases with disease progression. SMAD4 loss, and to a lesser extent weak expression, is strongly associated with poor survival regardless of stage. Clin Cancer Res; 22(12); 3037–47. ©2016 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-15-0939

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Cited by

See all 87

Metadata

Authors
Yan, P., Klingbiel, D., Saridaki, Z., Ceppa, P., Curto, M., McKee, T. A., Roth, A., Tejpar, S., Delorenzi, M., Bosman, F. T., & Fiocca, R.
Affiliations
  • University of Lausanne (CH)
  • Swiss Group For Clinical Cancer Research (CH)
  • University of Crete (GR)
  • Ospedale Policlinico San Martino (IT)
  • University Hospital of Geneva (CH)
  • Universitair Ziekenhuis Leuven (BE)
  • SIB Swiss Institute of Bioinformatics (CH)
  • 1Institute of Pathology, University of Lausanne, Lausanne, Switzerland.
Corresponding author
Fiocca, Roberto
Venue
Clinical Cancer Research
Published
2016-06-14
Volume
22
Issue
12
Pages
3037-3047
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2290450257
Cited by
78
References
55
Citations by year
2026: 6 · 2025: 9 · 2024: 9 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 4
FWCI
7.56
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Pfizer
  • Hellenic Society of Medical Oncology
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
SMAD4, colon cancer, protein expression loss, prognostic factors, relapse-free survival, overall survival, liver metastasis, colorectal adenoma, microsatellite instability, disease progression, stage II and III colon cancer
MeSH terms
Adenoma, Colonic Neoplasms, Humans, Immunohistochemistry, Liver Neoplasms, Prognosis, RNA, Messenger, Biomarkers, Tumor, Disease Progression, Disease-Free Survival, Smad4 Protein, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-15-0939
The paper
Yan, P., Klingbiel, D., Saridaki, Z., Ceppa, P., Curto, M., McKee, T. A., Roth, A., Tejpar, S., Delorenzi, M., Bosman, F. T., & Fiocca, R. (2016). Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-15-0939

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.